Europe Biologics Contract Manufacturing Market Size & Outlook

The biologics contract manufacturing market in Europe is expected to reach a projected revenue of US$ 7,432.0 million by 2030. A compound annual growth rate of 10.3% is expected of Europe biologics contract manufacturing market from 2021 to 2030.
Revenue, 2020 (US$M)
$2,784.5
Forecast, 2030 (US$M)
$7,432.0
CAGR, 2021 - 2030
10.3%
Report Coverage
Europe

Europe biologics contract manufacturing market, 2018-2030 (US$M)

Europe

Europe biologics contract manufacturing market highlights

  • The Europe biologics contract manufacturing market generated a revenue of USD 2,784.5 million in 2020.
  • The market is expected to grow at a CAGR of 10.3% from 2021 to 2030.
  • In terms of segment, mabs was the largest revenue generating product in 2020.
  • MABs is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2021 to 2030.

Europe data book summary

Market revenue in 2020USD 2,784.5 million
Market revenue in 2030USD 7,432.0 million
Growth rate10.3% (CAGR from 2020 to 2030)
Largest segmentMabs
Fastest growing segmentMABs
Historical data covered2018 - 2019
Base year for estimation2020
Forecast period covered2021 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMABs, Recombinant Protein
Key market players worldwideWuXi Biologics (Cayman) Inc, FUJIFILM Holdings Corp, Boehringer Ingelheim, Lonza Group Ltd, AbbVie Inc, Catalent Inc, Merck & Co Inc, Thermo Fisher Scientific Inc, Eurofins Scientific SE, Abzena, Samsung BioLogics

Other key industry trends

  • In terms of revenue, Europe region accounted for 21.8% of the global biologics contract manufacturing market in 2020.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 9,214.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biologics Contract Manufacturing Market Companies

Name Profile # Employees HQ Website

Europe biologics contract manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract manufacturing market will help companies and investors design strategic landscapes.


Mabs was the largest segment with a revenue share of 57.9% in 2020. Horizon Databook has segmented the Europe biologics contract manufacturing market based on mabs, recombinant protein covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Biologics Contract Manufacturing Product Outlook (Revenue, USD Million, 2018-2030)
    • MABs
    • Recombinant Protein
    • Others
  • Europe Biologics Contract Manufacturing Indication Outlook (Revenue, USD Million, 2018-2030)
    • Oncology
    • Immunological Disorders
    • Cardiovascular Disorders (CVDs)
    • Hematological Disorders
    • Others

Reasons to subscribe to Europe biologics contract manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe biologics contract manufacturing market databook

  • Our clientele includes a mix of biologics contract manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biologics contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biologics contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe biologics contract manufacturing market size, by country, 2018-2030 (US$M)

Europe Biologics Contract Manufacturing Market Outlook Share, 2020 & 2030 (US$M)

Europe biologics contract manufacturing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more